Symbol
| PTPRC
| contributors: mct - updated : 12-01-2016
|
HGNC name
| protein tyrosine phosphatase, receptor type, C
|
HGNC id
| 9666
|
corresponding disease(s)
|
SCIDNK
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| somatic mutation
|  
|  
|  
|
abnormal splicing in hemophagocytic lymphohitiocytosis in association with perforin mutation | tumoral
| somatic mutation
|  
|  
| gain of function
|
in T-cell acute lymphoblastic leukemia | |
Susceptibility
|
to multiple sclerosis to Graves disease or hepatitis B infection to severe outcome in hepatitis C |
Variant & Polymorphism
SNP
| 138 G allele protecting against Graves disease or hepatitis B infection |
|
allele C77G associated to severe outcome in hepatitis C |
|
a SNP is associated with the response to anti-TNF therapy and an rheumatoid arthritis risk allele |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
antigenic marker with which to identify undifferentiated hematopoietic tumors |
| | | |
| bone marrow derived macrophages from Ptprc-deficient mice exhibit abnormal cell morphology and defective motility |